Zhongchao Inc. Implements 1-for-31 Share Consolidation to Strengthen Market Position
Zhongchao Inc. Announces 1-for-31 Share Consolidation
Zhongchao Inc., an internet technology platform focused on healthcare services, has recently declared a share consolidation in a 1-for-31 ratio. This strategic decision was made to solidify its position on the Nasdaq Capital Market, where its shares will continue to trade under the symbol "ZCMD" following the consolidation.
Background of the Share Consolidation
Set to take effect on June 8, 2026, the share consolidation involves merging every 31 Class A ordinary shares—with a par value of $0.008 each—into one single Class A ordinary share, now valued at $0.248. Similarly, the Class B ordinary shares will follow suit, consolidating on the same terms. This move not only aims to bolster the market performance of Zhongchao Inc. but also aligns with shareholder interests as it seeks to improve stock liquidity and attract potential investors.
Currently, Zhongchao has a total of 79,685,696 Class A shares and 624,972 Class B shares outstanding. Post-consolidation, the company will have approximately 2,570,507 Class A shares and 20,161 Class B shares in circulation. The adjustment ensures that no fractional shares will be issued; such shares will be rounded to the nearest whole number, enabling a smooth transition for shareholders.
What This Means for Shareholders
The share consolidation process has undergone proper governance, having received approval from the company’s shareholders on February 10, 2026, and subsequently by the board of directors on March 31, 2026. Importantly, this action will not alter any shareholder’s proportional ownership in the company.
By consolidating shares, Zhongchao Inc. aims to fulfill NASDAQ listing requirements while enhancing its appeal to institutional investors. Increased share price typically conveys stability and financial health, which could stimulate market confidence.
Zhongchao's Focus on Healthcare Innovation
As a platform-based internet technology company, Zhongchao is at the forefront of providing essential services to patients suffering from cancer and other critical health concerns. Through its